Protein-coding gene in the species Homo sapiens
Tyrosine-protein kinase ABL2 also known as Abelson-related gene (Arg) is an enzyme that in humans is encoded by the ABL2 gene .[ 5] [ 6]
Function
ABL2 is a cytoplasmic tyrosine kinase which is closely related to but distinct from ABL1 . The similarity of the proteins includes the tyrosine kinase domains and extends amino-terminal to include the SH2 and SH3 domains. ABL2 is expressed in both normal and tumor cells. The expression of ABL2 gene is higher in KRAS mutant non-small cell lung cancer.[ 7] The ABL2 gene product is expressed as two variants bearing different amino termini, both approximately 12-kb in length.[ 6]
Interactions
ABL2 has been shown to interact with three proteins: Abl gene ,[ 8] catalase ,[ 9] and SORBS2 .[ 10] The protein Abl gene is also known as abelson murine leukemia viral oncogene homolog 1 and is a protein that is encoded by the human ABL1 gene.[ 11] Catalase is a common enzyme that catalyzes the decomposition of hydrogen peroxide to water and oxygen .[ 12] SORBS2 is also known as Sorbin and SH3 domain-containing protein 2 and is a protein encoded by the SORBS2 gene in humans.[ 6] [ 10] [ 13]
References
^ a b c GRCh38: Ensembl release 89: ENSG00000143322 – Ensembl , May 2017
^ a b c GRCm38: Ensembl release 89: ENSMUSG00000026596 – Ensembl , May 2017
^ "Human PubMed Reference:" . National Center for Biotechnology Information, U.S. National Library of Medicine .
^ "Mouse PubMed Reference:" . National Center for Biotechnology Information, U.S. National Library of Medicine .
^ Kruh GD, King CR, Kraus MH, Popescu NC, Amsbaugh SC, McBride WO, Aaronson SA (Jan 1987). "A novel human gene closely related to the abl proto-oncogene" . Science . 234 (4783): 1545– 8. doi :10.1126/science.3787260 . PMID 3787260 .
^ a b c "Entrez Gene: ABL2 v-abl Abelson murine leukemia viral oncogene homolog 2 (arg, Abelson-related gene)" .
^ Nagy Á, Pongor LS, Szabó A, Santarpia M, Győrffy B (2017-02-15). "KRAS driven expression signature has prognostic power superior to mutation status in non-small cell lung cancer" . International Journal of Cancer . 140 (4): 930– 937. doi :10.1002/ijc.30509 . ISSN 1097-0215 . PMC 5299512 . PMID 27859136 .
^ Cao C, Leng Y, Li C, Kufe D (April 2003). "Functional interaction between the c-Abl and Arg protein-tyrosine kinases in the oxidative stress response" . J. Biol. Chem . 278 (15): 12961– 7. doi :10.1074/jbc.M300058200 . PMID 12569093 .
^ Cao C, Leng Y, Kufe D (August 2003). "Catalase activity is regulated by c-Abl and Arg in the oxidative stress response" . J. Biol. Chem . 278 (32): 29667– 75. doi :10.1074/jbc.M301292200 . PMID 12777400 .
^ a b Wang B, Golemis EA, Kruh GD (July 1997). "ArgBP2, a multiple Src homology 3 domain-containing, Arg/Abl-interacting protein, is phosphorylated in v-Abl-transformed cells and localized in stress fibers and cardiocyte Z-disks" . J. Biol. Chem . 272 (28): 17542– 50. doi :10.1074/jbc.272.28.17542 . hdl :20.500.12613/9174 . PMID 9211900 .
^ Szczylik C, Skorski T, Nicolaides NC, Manzella L, Malaguarnera L, Venturelli D, Gewirtz AM, Calabretta B (August 1991). "Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxynucleotides". Science . 253 (5019): 562– 5. Bibcode :1991Sci...253..562S . doi :10.1126/science.1857987 . PMID 1857987 .
^ Chelikani P, Fita I, Loewen PC (January 2004). "Diversity of structures and properties among catalases". Cell. Mol. Life Sci . 61 (2): 192– 208. doi :10.1007/s00018-003-3206-5 . hdl :10261/111097 . PMID 14745498 . S2CID 4411482 .
^ Nagase T, Ishikawa K, Suyama M, Kikuno R, Miyajima N, Tanaka A, Kotani H, Nomura N, Ohara O (Apr 1999). "Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro" . DNA Res . 5 (5): 277– 86. doi :10.1093/dnares/5.5.277 . PMID 9872452 .
Further reading
Bradley WD, Koleske AJ (2009). "Regulation of cell migration and morphogenesis by Abl-family kinases: emerging mechanisms and physiological contexts" . J Cell Sci . 122 (19): 3441– 54. doi :10.1242/jcs.039859 . PMC 2746129 . PMID 19759284 .
Pendergast AM (2003). "The Abl family kinases: mechanisms of regulation and signaling". Adv. Cancer Res . Advances in Cancer Research. 85 : 51– 100. doi :10.1016/S0065-230X(02)85003-5 . ISBN 0120066858 . PMID 12374288 .
Muller AJ, Pendergast AM, Havlik MH, et al. (1992). "A limited set of SH2 domains binds BCR through a high-affinity phosphotyrosine-independent interaction" . Mol. Cell. Biol . 12 (11): 5087– 93. doi :10.1128/mcb.12.11.5087 . PMC 360442 . PMID 1383690 .
Kruh GD, Perego R, Miki T, Aaronson SA (1990). "The complete coding sequence of arg defines the Abelson subfamily of cytoplasmic tyrosine kinases" . Proc. Natl. Acad. Sci. U.S.A . 87 (15): 5802– 6. Bibcode :1990PNAS...87.5802K . doi :10.1073/pnas.87.15.5802 . PMC 54416 . PMID 2198571 .
Kruh GD, King CR, Kraus MH, et al. (1987). "A novel human gene closely related to the abl proto-oncogene" . Science . 234 (4783): 1545– 8. doi :10.1126/science.3787260 . PMID 3787260 .
Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene . 138 (1– 2): 171– 4. doi :10.1016/0378-1119(94)90802-8 . PMID 8125298 .
Wang B, Kruh GD (1996). "Subcellular localization of the Arg protein tyrosine kinase". Oncogene . 13 (1): 193– 7. PMID 8700546 .
Wang B, Mysliwiec T, Feller SM, et al. (1996). "Proline-rich sequences mediate the interaction of the Arg protein tyrosine kinase with Crk". Oncogene . 13 (7): 1379– 85. PMID 8875975 .
Wang B, Golemis EA, Kruh GD (1997). "ArgBP2, a multiple Src homology 3 domain-containing, Arg/Abl-interacting protein, is phosphorylated in v-Abl-transformed cells and localized in stress fibers and cardiocyte Z-disks" . J. Biol. Chem . 272 (28): 17542– 50. doi :10.1074/jbc.272.28.17542 . hdl :20.500.12613/9174 . PMID 9211900 .
Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene . 200 (1– 2): 149– 56. doi :10.1016/S0378-1119(97)00411-3 . PMID 9373149 .
Koval AP, Blakesley VA, Roberts CT, et al. (1998). "Interaction in vitro of the product of the c-Crk-II proto-oncogene with the insulin-like growth factor I receptor" . Biochem. J . 330 (2): 923– 32. doi :10.1042/bj3300923 . PMC 1219226 . PMID 9480911 .
Hashimoto Y, Katayama H, Kiyokawa E, et al. (1998). "Phosphorylation of CrkII adaptor protein at tyrosine 221 by epidermal growth factor receptor" . J. Biol. Chem . 273 (27): 17186– 91. doi :10.1074/jbc.273.27.17186 . PMID 9642287 .
Danial NN, Losman JA, Lu T, et al. (1998). "Direct interaction of Jak1 and v-Abl is required for v-Abl-induced activation of STATs and proliferation" . Mol. Cell. Biol . 18 (11): 6795– 804. doi :10.1128/mcb.18.11.6795 . PMC 109263 . PMID 9774693 .
Cao C, Ren X, Kharbanda S, et al. (2001). "The ARG tyrosine kinase interacts with Siva-1 in the apoptotic response to oxidative stress" . J. Biol. Chem . 276 (15): 11465– 8. doi :10.1074/jbc.C100050200 . PMC 3476318 . PMID 11278261 .
Yu HH, Zisch AH, Dodelet VC, Pasquale EB (2001). "Multiple signaling interactions of Abl and Arg kinases with the EphB2 receptor" . Oncogene . 20 (30): 3995– 4006. doi :10.1038/sj.onc.1204524 . PMID 11494128 .
Endo A, Nagashima K, Kurose H, et al. (2002). "Sphingosine 1-phosphate induces membrane ruffling and increases motility of human umbilical vein endothelial cells via vascular endothelial growth factor receptor and CrkII" . J. Biol. Chem . 277 (26): 23747– 54. doi :10.1074/jbc.M111794200 . PMID 11956190 .
Abassi YA, Vuori K (2002). "Tyrosine 221 in Crk regulates adhesion-dependent membrane localization of Crk and Rac and activation of Rac signaling" . EMBO J . 21 (17): 4571– 82. doi :10.1093/emboj/cdf446 . PMC 126186 . PMID 12198159 .
Bianchi C, Muradore I, Corizzato M, et al. (2002). "The expression of the non-receptor tyrosine kinases Arg and c-abl is differently modulated in B lymphoid cells at different stages of differentiation" . FEBS Lett . 527 (1– 3): 216– 222. doi :10.1016/S0014-5793(02)03233-7 . PMID 12220663 .
Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences" . Proc. Natl. Acad. Sci. U.S.A . 99 (26): 16899– 903. Bibcode :2002PNAS...9916899M . doi :10.1073/pnas.242603899 . PMC 139241 . PMID 12477932 .
Salomon AR, Ficarro SB, Brill LM, et al. (2003). "Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry" . Proc. Natl. Acad. Sci. U.S.A . 100 (2): 443– 8. Bibcode :2003PNAS..100..443S . doi :10.1073/pnas.2436191100 . PMC 141014 . PMID 12522270 .
External links
PDB gallery
1ab2 : THREE-DIMENSIONAL SOLUTION STRUCTURE OF THE SRC HOMOLOGY 2 DOMAIN OF C-ABL
1abo : CRYSTAL STRUCTURE OF THE COMPLEX OF THE ABL TYROSINE KINASE SH3 DOMAIN WITH 3BP-1 SYNTHETIC PEPTIDE
1abq : CRYSTAL STRUCTURE OF THE UNLIGANDED ABL TYROSINE KINASE SH3 DOMAIN
1bbz : CRYSTAL STRUCTURE OF THE ABL-SH3 DOMAIN COMPLEXED WITH A DESIGNED HIGH-AFFINITY PEPTIDE LIGAND: IMPLICATIONS FOR SH3-LIGAND INTERACTIONS
1fpu : CRYSTAL STRUCTURE OF ABL KINASE DOMAIN IN COMPLEX WITH A SMALL MOLECULE INHIBITOR
1iep : CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH STI-571.
1ju5 : Ternary complex of an Crk SH2 domain, Crk-derived phophopeptide, and Abl SH3 domain by NMR spectroscopy
1m52 : Crystal Structure of the c-Abl Kinase domain in complex with PD173955
1opj : Structural basis for the auto-inhibition of c-Abl tyrosine kinase
2e2b : Crystal structure of the c-Abl kinase domain in complex with INNO-406
2f4j : Structure of the Kinase Domain of an Imatinib-Resistant Abl Mutant in Complex with the Aurora Kinase Inhibitor VX-680
2g1t : A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain
2g2f : A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain
2g2h : A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain
2g2i : A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain
2gqg : X-ray Crystal Structure of Dasatinib (BMS-354825) Bound to Activated ABL Kinase Domain
2hiw : Crystal Structure of Inactive Conformation Abl Kinase Catalytic Domain Complexed with Type II Inhibitor
2hyy : Human Abl kinase domain in complex with imatinib (STI571, Glivec)
2hz0 : Abl kinase domain in complex with NVP-AEG082
2hz4 : Abl kinase domain unligated and in complex with tetrahydrostaurosporine
2hzi : Abl kinase domain in complex with PD180970
2hzn : Abl kinase domain in complex with NVP-AFG210
Activity Regulation Classification Kinetics Types